Patent ID: 9266884
Filing Date: 2016-02-23
CPC Classification: A61K,C07D

Claim Text:
1. A method of treating a condition selected from the group consisting of bone resorption, osteoporosis, restenosis, diabetic retinopathy, macular degeneration, angiogenesis, atherosclerosis, cancer, tumor growth, and metastasis; eliciting an αvβ3 integrin receptor antagonizing effect wherein the effect is inhibition of bone resorption, restenosis, angiogenesis, diabetic retinopathy, macular degeneration, tumor growth, or metastasis; or inhibiting bone resorption in a human subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of formula I: or a pharmaceutically acceptable salt or solvate thereof, wherein X is selected from CH and N; Y is selected from CH and N; R R or R provided that the compound of formula I contains at least one fluorine atom.